Iris Edwards to Proteoglycans
This is a "connection" page, showing publications Iris Edwards has written about Proteoglycans.
Connection Strength
1.128
-
Edwards IJ. Proteoglycans in prostate cancer. Nat Rev Urol. 2012 Feb 21; 9(4):196-206.
Score: 0.359
-
Hu Y, Sun H, Owens RT, Wu J, Chen YQ, Berquin IM, Perry D, O'Flaherty JT, Edwards IJ. Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. Neoplasia. 2009 Oct; 11(10):1042-53.
Score: 0.305
-
Sun H, Berquin IM, Edwards IJ. Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells. Cancer Res. 2005 May 15; 65(10):4442-7.
Score: 0.225
-
Edwards IJ, Terry JG, Bell-Farrow AD, Cefalu WT. Improved glucose control decreases the interaction of plasma low-density lipoproteins with arterial proteoglycans. Metabolism. 2002 Oct; 51(10):1223-9.
Score: 0.187
-
Vogl-Willis CA, Edwards IJ. High glucose-induced alterations in subendothelial matrix perlecan leads to increased monocyte binding. Arterioscler Thromb Vasc Biol. 2004 May; 24(5):858-63.
Score: 0.052